Literature DB >> 1491010

Calphobindins (placental annexins) inhibit protein kinase C.

S Shibata1, H Sato, M Maki.   

Abstract

Calphobindins (CPBs, placental annexins) are intracellular Ca(2+)- and phospholipid-dependent proteins like protein kinase C [EC 2.7.1.37]. We investigated the inhibitory effects of calphobindins on the protein kinase C activity in vitro. CPB I inhibited the protein kinase C activity for both histone phosphorylation and lipocortin phosphorylation, but CPB II and CPB III inhibited only the protein kinase C activity for histone phosphorylation. In the case of histone phosphorylation, all CPBs inhibited the protein kinase C activity in a concentration-dependent manner, and the IC50 (concentration required for 50% inhibition) value of CPB I was 70 nM. The inhibition of protein kinase C by CPB I was Ca(2+)-dependent, and did not disappear upon increasing the concentration of phosphatidyl-serine. Kinetic analysis by double-reciprocal plots indicated that CPB I interacted not only with phosphatidylserine but also with protein kinase C. Although CPB I partially interacts with phospholipid, it is conceivable that the inhibitory action of CPB I on protein kinase C results from direct interaction of CPB I with protein kinase C. Since CPBs are mainly present under the plasma membrane, it is presumed that CPB I is an endogenous inhibitor of protein kinase C, and according to intracellular circumstances, CPB II and CPB III may also be endogenous inhibitors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1491010     DOI: 10.1093/oxfordjournals.jbchem.a123937

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  7 in total

1.  Relocation of annexin V to platelet membranes is a phosphorylation-dependent process.

Authors:  P J Trotter; M A Orchard; J H Walker
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

2.  Annexin V inhibits protein kinase C activity via a mechanism of phospholipid sequestration.

Authors:  T Dubois; J P Mira; D Feliers; E Solito; F Russo-Marie; J P Oudinet
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

3.  In vivo and in vitro phosphorylation of annexin II in T cells: potential regulation by annexin V.

Authors:  T Dubois; J P Oudinet; F Russo-Marie; B Rothhut
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

4.  Annexin 5 as a potential regulator of annexin 1 phosphorylation by protein kinase C. In vitro inhibition compared with quantitative data on annexin distribution in human endothelial cells.

Authors:  P Raynal; F Hullin; J M Ragab-Thomas; J Fauvel; H Chap
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

5.  Endocytosis occurs independently of annexin VI in human A431 cells.

Authors:  E Smythe; P D Smith; S M Jacob; J Theobald; S E Moss
Journal:  J Cell Biol       Date:  1994-02       Impact factor: 10.539

6.  Annexin V-induced rat Leydig cell proliferation involves Ect2 via RhoA/ROCK signaling pathway.

Authors:  Jun Jing; Li Chen; Hai-Yan Fu; Kai Fan; Qi Yao; Yi-Feng Ge; Jin-Chun Lu; Bing Yao
Journal:  Sci Rep       Date:  2015-03-24       Impact factor: 4.379

7.  Annexin VI has tumour-suppressor activity in human A431 squamous epithelial carcinoma cells.

Authors:  J Theobald; A Hanby; K Patel; S E Moss
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.